UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Migraine
Abstract Introduction: Migraine is a primary headache disorder, which leads to diminished health‐related quality of life (HRQoL). There is limited…
Mark W. Weatherall
UK Medical Cannabis Registry: A clinical outcomes analysis for insomnia
Abstract Insomnia affects approximately 10% of adults globally. Current treatments have their limitations, and there is growing evidence on the…
UK Medical Cannabis Registry: Assessment of clinical outcomes in patients with insomnia
Abstract Introduction: The primary aim of this study was to assess changes in sleep‐specific health‐related quality of life (HRQoL) for…
An observational study of clinical outcome measures in patients treated with cannabis‐based medicinal products on the UK Medical Cannabis Registry
Abstract Introduction: While there is increasing evidence of the effects of cannabis‐based medicinal products (CBMPs) on health‐related quality of life…
Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy—Analysis from the UK Medical Cannabis Registry
Abstract Background There is a paucity of high-quality evidence of the efficacy and safety of cannabis-based medicinal products in treatment…
An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patients
Abstract Aim: Cannabis‐based medicinal products (CBMPs) are prescribed with increased frequency, despite a paucity of high‐quality randomized controlled trials. The…